Yahoo Web Search

Search results

    • Novavax Reports First Quarter 2024 Financial Results and Operational Highlights

      WJTV Jackson· 3 hours ago

      ...combination product near-term milestones, plus ongoing tiered royalties on product salesUp to $200 million in milestones plus royalties for each new vaccine developed utilizing Novavax's Matrix-MTM adjuvantAnnounces addition of standalone influenza vaccine to Phase 3 COVID-19-Influenza...